
Defender Pharmaceuticals, Inc.: Developing anti-nausea solutions for human and veterinary markets.
Defender Pharmaceuticals, Inc., founded in St. Louis, Missouri, is a development-stage pharmaceutical company dedicated to discovering, developing, and partnering on anti-vomiting and anti-nausea compounds. The company's core mission is to provide effective solutions for motion sickness and major depressive disorder (MDD) for both human and veterinary markets. Defender Pharmaceuticals aims to enhance the quality of life for its users through innovative therapeutic products.
Notable figures associated with Defender Pharmaceuticals include leading scientists and industry experts in pharmacology and biotechnology. The company has achieved significant milestones in its pipeline development, particularly in addressing motion sickness and MDD. Its impact is seen in its commitment to advancing healthcare solutions that cater to both human and animal needs, positioning itself as a crucial player in the pharmaceutical industry.

Amerigen Pharmaceuticals
amerigenpharma.com

Vm Discovery
vmdiscovery.com

NeuroGenetic Pharmaceuticals

KinDex Pharmaceuticals

Mojave Pharma

WayPath Pharma
waypathpharma.com

PleoPharma
pleopharma.com

Fennec Pharmaceuticals
fennecpharma.com

Fidelis Pharmaceuticals
fidelisrx.com

Vertice Pharma

Pharmos
pharmoscorp.com

Stargazer Pharmaceuticals

Deltanoid Pharmaceuticals

Dauntless Pharmaceuticals

PIN Pharma
pinpharma.com
Companies similar to Defender Pharmaceuticals include Amerigen Pharmaceuticals, Vm Discovery, NeuroGenetic Pharmaceuticals and KinDex Pharmaceuticals.
Defender Pharmaceuticals' headquarters is located in St. Louis, MO, US.
Defender Pharmaceuticals' most recent funding round was for $70M (USD) in July 2023.
As of Jul 18, 2023, Defender Pharmaceuticals has raised a total of $70M (USD).
Defender Pharmaceuticals has 30 employees as of Feb 4, 2024.